All Topics

Technology

Art

Markwayne Mullin's kratom industry investments raise conflict of interest concerns

Anthony L. Fisher

3h ago· 5 min readenNews

Summary

A New York Times report reveals that Homeland Security Secretary Markwayne Mullin, while serving as a senator from Oklahoma, played a significant role in an influence campaign advocating for kratom—a gas station supplement linked to liver toxicity, seizures, and substance use disorder. Mullin endorsed proposed legislation favorable to the kratom industry, raising concerns about a conflict of interest given his personal investments in the sector. The article highlights the ethical questions surrounding a top homeland security official's ties to a controversial supplement industry.

Source

bskyMarkwayne Mullin's kratom industry investments raise conflict of interest concernsms.now

Key quotes

· 3 pulled

A New York Times report earlier this week revealed the significant role Mullin has played in an influence campaign advocating for kratom

Kratom has also been found in the system of thousands of people who died of drug overdoses

What do gas station drugs, conflicts of interest and the Trump administration have in common? Homeland Security Secretary Markwayne Mullin.

Snippet from the RSS feed

A New York Times report revealed the Homeland Security secretary’s significant role in an influence campaign advocating for kratom.

You might also wanna read

Kratom advocates split as 7-OH concentrates spark internal battle, drawing RFK Jr. into the fray

The article covers the escalating conflict within the kratom community over 7-hydroxymitragynine (7-OH), a concentrated alkaloid derived fro

Wired·6d ago

Satirical Profile: Markwayne Mullin's Fictional Biography as Homeland Security Nominee

The article is a satirical political profile from The Onion about Senator Markwayne Mullin, who has been nominated as Secretary of Homeland

The Onion·3mo ago

Conflicts of interest threaten integrity of GLP-1 therapy guidance, experts warn

This article discusses the risks of conflicts of interest in clinical guidance for GLP-1 receptor agonists (like Ozempic, Wegovy) used for o

bit.ly·2d ago

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica

bmj.com·2d ago

Anti-Science Advocacy Leaders Profit from Make America Healthy Again Movement

The article exposes how leaders of the Make America Healthy Again (MAHA) movement are profiting financially from anti-science advocacy, part